NCT00004163 2017-04-18Trastuzumab in Treating Patients With Advanced Salivary Gland CancerDana-Farber Cancer InstitutePhase 2 Completed14 enrolled
NCT00004074 2013-02-28Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuNational Cancer Institute (NCI)Phase 1 Completed15 enrolled
NCT00005842 2013-02-11Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerNational Cancer Institute (NCI)Phase 1 Completed24 enrolled